These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15450039)

  • 61. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
    Giugliano RP; Wiviott SD; Blazing MA; De Ferrari GM; Park JG; Murphy SA; White JA; Tershakovec AM; Cannon CP; Braunwald E
    JAMA Cardiol; 2017 May; 2(5):547-555. PubMed ID: 28291866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.
    Newman AB; Spiekerman CF; Enright P; Lefkowitz D; Manolio T; Reynolds CF; Robbins J
    J Am Geriatr Soc; 2000 Feb; 48(2):115-23. PubMed ID: 10682939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.
    Krumholz HM; Seeman TE; Merrill SS; Mendes de Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Berkman LF
    JAMA; 1994 Nov; 272(17):1335-40. PubMed ID: 7772105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sex-based differences in risk factors for incident myocardial infarction and stroke in the UK Biobank.
    Remfry E; Ardissino M; McCracken C; Szabo L; Neubauer S; Harvey NC; Mamas MA; Robson J; Petersen SE; Raisi-Estabragh Z
    Eur Heart J Qual Care Clin Outcomes; 2024 Mar; 10(2):132-142. PubMed ID: 37218687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study.
    Suchy-Dicey AM; Wallace ER; Mitchell SV; Aguilar M; Gottesman RF; Rice K; Kronmal R; Psaty BM; Longstreth WT
    Am J Hypertens; 2013 Oct; 26(10):1210-7. PubMed ID: 23744496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myocardial Infarction, Stroke, and All-Cause Mortality according to Low-Density Lipoprotein Cholesterol Level in the Elderly, a Nationwide Study.
    Lee YB; Koo M; Noh E; Hwang SY; Kim JA; Roh E; Hong SH; Choi KM; Baik SH; Cho GJ; Yoo HJ
    Diabetes Metab J; 2022 Sep; 46(5):722-732. PubMed ID: 35255552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.
    Cheng KH; Chu CS; Lin TH; Lee KT; Sheu SH; Lai WT
    Crit Care Med; 2015 Jun; 43(6):1255-64. PubMed ID: 25738856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study).
    Boland LL; Folsom AR; Sorlie PD; Taylor HA; Rosamond WD; Chambless LE; Cooper LS
    Am J Cardiol; 2002 Nov; 90(9):927-31. PubMed ID: 12398956
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between plasma lipids and all-cause mortality in nondemented elderly.
    Schupf N; Costa R; Luchsinger J; Tang MX; Lee JH; Mayeux R
    J Am Geriatr Soc; 2005 Feb; 53(2):219-26. PubMed ID: 15673344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Fukunaga A; Yokoya T; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Miyamoto T; Sasaki N; Ogasawara T; Gonmori N; Yamamoto K; Hori A; Tomita K; Nagahama S; Konishi M; Katayama N; Morioka H; Kabe I; Mizoue T; Dohi S
    J Atheroscler Thromb; 2022 Sep; 29(9):1295-1306. PubMed ID: 34690212
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma lipids and cardiovascular risk: a POSCH report. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Boen JR; Nguyen PA; Williams SE; Matts JP
    Atherosclerosis; 2001 Jan; 154(1):221-7. PubMed ID: 11137103
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
    Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ
    Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study.
    Frost PH; Verter J; Miller D
    Am Heart J; 1987 Jun; 113(6):1356-64. PubMed ID: 3591604
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
    Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
    Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.